Grants and Contributions:
Title:
Multiplex electrochemical immunosensor for cardiac biomarkers
Agreement Number:
952760
Agreement Value:
$203,000.00
Agreement Date:
Jun 1, 2020 - Feb 28, 2022
Description:
The project will involve the development of a multiplex cardiac marker electrochemical immunosensor prototype, for the simultaneous quantitative detection of human cardiac troponin I (cTnI), creatine kinase MB (CK-MB) and myoglobin for the rapid diagnosis and treatment of acute myocardial infarction (AMI).
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Burnaby, British Columbia, CA V5C 6N3
Reference Number:
172-2020-2021-Q1-952760
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
818765232
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 59 days.
Amendment Date
Oct 13, 2021
Recipient's Legal Name:
eSenso Biotech Inc.
Federal Riding Name:
Burnaby South
Federal Riding Number:
59003
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: